Stock Price Quote

KREBS BIOCHEMICALS & INDUSTRIES LTD.

NSE : KREBSBIOBSE : 524518ISIN CODE : INE268B01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE124.102.1 (+1.72 %)
PREV CLOSE ( ) 122.00
OPEN PRICE ( ) 124.35
BID PRICE (QTY) 123.90 (67)
OFFER PRICE (QTY) 126.00 (40)
VOLUME 2113
TODAY'S LOW / HIGH ( )121.50 126.90
52 WK LOW / HIGH ( )66 147.9
NSE124.002.3 (+1.89 %)
PREV CLOSE( ) 121.70
OPEN PRICE ( ) 122.85
BID PRICE (QTY) 123.85 (16)
OFFER PRICE (QTY) 124.00 (26)
VOLUME 18520
TODAY'S LOW / HIGH( ) 121.00 129.40
52 WK LOW / HIGH ( )64.4 148.8
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 02-12 1991
Management Info
R T Ravi - Chairman Avinash Ravi - Managing Director
Registered Office

Address Kothapalli Village,Anakapalli,Kasimkota Mandal,
Vishakhapatnam,
Andhra Pradesh-531031

Phone

Email marketing@krebsbiochem.com / investors@krebsbiochem.com

Website www.krebsbiochem.com

Registrars Details
K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

13Apr Price Movement Clarification
The Company is submitting its reply for the clarification sought from th..
12Apr Clarification sought from Krebs Bioch
The Exchange has sought clarification from Krebs Biochemicals & Industri..
07Apr Announcement under Regulation 30 (LOD
.Pursuant to the exercise of further conversion option by Ipca Laborator..
06Apr Allotment Of 1940000 Shares Upon Conv
Pursuant to the exercise of further conversion option by Ipca Laboratori..
06Apr Allotment of Equity Shares
inter alia, 1.Pursuant to our intimation letters dated 1st February, 202..

Financials

in Millions
QTR Dec 20 ANNUAL 20
Net Profit-82.61-288.72
Gross Profit -82.61 -288.72
Operating Profit -55.95-182.65
Net Sales 95.78334.12

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  15821.25 (2.57%)
M.Cap ( in Cr)33531.40
Themis Medicare (BSE)
peergroup  451.20 (20.00%)
M.Cap ( in Cr)414.58
Neuland Laboratories (BSE)
peergroup  2686.00 (2.50%)
M.Cap ( in Cr)3448.03
Sanofi India (BSE)
peergroup  7758.50 (0.80%)
M.Cap ( in Cr)17797.14
Alkem Laboratories (BSE)
peergroup  2911.50 (1.74%)
M.Cap ( in Cr)34866.95

Shareholding Pattern

PROMOTERS 70.03%
NON-INSTITUTION 29.96%
FI/BANKS/INSURANCE 0%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
No Data Found

About Krebs Biochemicals & Industries Ltd.

Krebs Biochemicals & Industries Ltd. was incorporated in the year 1991. Its today's share price is 124.1. Its current market capitalisation stands at Rs 269.94 Cr. In the latest quarter, company has reported Gross Sales of Rs. 334.12 Cr and Total Income of Rs.337.77 Cr. The company's management includes Taruni Banda, Satish Khivsara, Tangirala Malati, Raj Kamal Prasad Verma, GVL Prasad, EJ Babu, Manish Jain, Avinash Ravi, R T Ravi.

It is listed on the BSE with a BSE Code of 524518 , NSE with an NSE Symbol of KREBSBIO and ISIN of INE268B01013. It's Registered office is at Kothapalli Village,Anakapalli,Kasimkota MandalVishakhapatnam-531031, Andhra Pradesh. Their Registrars are ACC Ltd. It's auditors are Bhavani & Co, Pavuluri & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)